The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Innate and Adaptive Interferons Suppress IL-1α and IL-1β Production by Distinct Pulmonary Myeloid Subsets during Mycobacterium tuberculosis Infection
Open accessAbstract
Interleukin-1 (IL-1) receptor signaling is necessary for control of Mycobacterium tuberculosis (Mtb) infection, yet the role of its two ligands, IL-1α and IL-1β, and their regulation in vivo are poorly understood. Here, we showed that both IL-1α and IL-1β are critically required for host resistance and identified two multifunctional inflammatory monocyte-macrophage and DC populations that coexpressed both IL-1 species at the single-cell level in lungs of Mtb-infected mice. Moreover, we demonstrated that interferons (IFNs) played important roles in regulating IL-1 production by these cells in vivo. Type I interferons inhibited IL-1 production by both subsets whereas CD4(+) T cell-derived IFN-γ selectively suppressed monocyte-macrophages. These data provide a cellular basis for both the anti-inflammatory effects of IFNs and probacterial functions of type I IFNs during Mtb infection and reveal differential regulation of IL-1 production by distinct cell populations as an additional layer of complexity in the activity of IL-1 in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-1β is massively induced upon infection of macrophages with M. tuberculosis, and it appears to play important roles in anti-mycobacterial immune defenses because knockout mice are more susceptible to this infection (98)”
From Macrophage defense mechanisms against intracellular bacteria (2015) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection.
Serbina, N., Salazar-Mather, T. P., Biron, C., Kuziel, W., & Pamer, E. (2003) · Immunity · doi:10.1016/s1074-7613(03)00171-7 · Cited by 1,293
Flynn, J., & Chan, J. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.93 · Cited by 1,144
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
Guarda, G., Braun, M., Staehli, F., Tardivel, A., Mattmann, C., Förster, I., Farlik, M., Decker, T., Pasquier, R. D., Romero, P. J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.006 · Cited by 924
Type I interferon: friend or foe?
Trinchieri, G. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20101664 · Cited by 838
North, R. J., & Jung, Y. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104635 · Cited by 677
Cheong, C., de Matos, I. G., Choi, J., Dandamudi, D. B., Shrestha, E., Longhi, M. P., Jeffrey, K. L., Anthony, R. M., Kluger, C., Nchinda, G., et al. (2010) · Cell · doi:10.1016/j.cell.2010.09.039 · Cited by 640
Manca, C., Tsenova, L., Bergtold, A., Freeman, S. L., Tovey, M. G., Musser, J. M., Barry, C. E., Freedman, V. H., & Kaplan, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091096998 · Cited by 590
Cited by
Sorted by citations
Items 301–400 of 418
Taurine transport is a critical modulator of ionic fluxes during NLRP3 inflammasome activation
Rossi-Smith, P., Kim, J., Skirlo, K., Ferris, T. J., Green, J., Stek, C. J., Huse, K. K., Mortimer, P. M., Olona, A., Wieder, C., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116317 · Cited by 10
Type I interferons in tuberculosis pathogenesis and prevention
Munson, C. W., & Kaushal, D. (2025) · Trends in Microbiology · doi:10.1016/j.tim.2025.11.003 · Cited by 14
Devalraju, K. P., Tripathi, D., Neela, V. S. K., Paidipally, P., Radhakrishnan, R. K., Singh, K. P., Ansari, M. S., Jaeger, M., Netea-Maier, R. T., Netea, M. G., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.148271 · Cited by 11
Lee, S., Clémentine, C., & Kim, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-52606-2 · Cited by 11
Airway microbiome signature accurately discriminates Mycobacterium tuberculosis infection status
Kayongo, A., Ntayi, M. L., Olweny, G., Kyalo, E., Ndawula, J. C., Ssengooba, W., Kigozi, E., Kalyesubula, R., Munana, R., Namaganda, J., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110142 · Cited by 10
Caspase-1 inhibits IFN-β production via cleavage of cGAS during M. bovis infection
Liao, Y., Liu, C., Wang, J., Song, Y., Sabir, N., Hussain, T. A., Yao, J., Luo, L., Wang, H., Cui, Y., et al. (2021) · Veterinary Microbiology · doi:10.1016/j.vetmic.2021.109126 · Cited by 10
Kwon, K. W., Kim, L., Kang, S. M., Lee, J. M., Choi, E., Park, J., Hong, J. J., & Shin, S. J. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15838 · Cited by 10
Gong, W., Liang, Y., Wang, J., Liu, Y., Xue, Y., Mi, J., Li, P., Wang, X., Wang, L., & Wu, X. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01438-22 · Cited by 10
Nosik, M. N., Ryzhov, K., Kudryavtseva, А. V., Kuimova, U., Kravtchenko, A., Sobkin, A., Zverev, V. V., & Свитич, О. А. (2024) · Biomedicines · doi:10.3390/biomedicines12050954 · Cited by 11
Inflammasome Activation and Function During Infection with Mycobacterium Tuberculosis
Ablasser, A., & Dorhoi, A. (2016) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-41171-2_9 · Cited by 9
Subversion of mouse dendritic cell subset function by bacterial pathogens
Papadopoulos, A., & Gorvel, J. (2015) · Microbial Pathogenesis · doi:10.1016/j.micpath.2015.10.004 · Cited by 9
Konowich, J., Gopalakrishnan, A., Dietzold, J., Verma, S., Bhatt, K., Rafi, W., & Salgame, P. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1601651 · Cited by 9
Interleukin-1 receptor antagonist is a conserved factor for exacerbating tuberculosis susceptibilityPreprint
Lee, O. V., Pathak, E., Hernández-Bazán, S., Ji, D. X., Rosa, B. A., Jaye, D. L., Suliman, S., Mitreva, M., Gabay, C., Vance, R. E., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.27.564420 · Cited by 9
Cytokine and chemokine profiles in pulmonary tuberculosis with pre-diabetes
Rajamanickam, A., Kothandaraman, S. P., Kumar, N. P., Viswanathan, V., Shanmugam, S., Hissar, S. S., Nott, S., Kornfeld, H., & Babu, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1447161 · Cited by 10
Gupta, S. K., Wilson, T., Maclean, P. H., Rehm, B. H. A., Heiser, A., Buddle, B. M., & Wedlock, D. N. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1087015 · Cited by 9
A TNF-IL-1 circuit controls Yersinia within intestinal pyogranulomas
Matsuda, R., Sorobetea, D., Zhang, J., Peterson, S. T., Grayczyk, J. P., Yost, W., Apenes, N., Kovalik, M. E., Herrmann, B. I., O’Neill, R. J., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20230679 · Cited by 8
Self-citationJørgensen, M. J., Nore, K. G., Aass, H. C. D., Layre, E., Nigou, J., Mortensen, R. J., Taskén, K., Kvale, D., Jenum, S., Tonby, K., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.669623 · Cited by 9
Curto, P., Santa, C., Cortes, L., Manadas, B. J., & Simões, I. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00814-21 · Cited by 8
Nobs, E., Laschanzky, K., Munke, K., Movert, E., Valfridsson, C., & Carlsson, F. (2024) · mBio · doi:10.1128/mbio.00384-24 · Cited by 7
For Better or Worse: Type I Interferon Responses in Bacterial Infection
Xia, A., Li, X., Zhao, C., Meng, X., Kari, G., & Wang, Y. (2025) · Pathogens · doi:10.3390/pathogens14030229 · Cited by 7
Qin, Y., Xu, J., Wang, Q., & Shi, J. (2025) · Virulence · doi:10.1080/21505594.2025.2542466 · Cited by 9
Bobba, S., Chauhan, K. S., Akter, S., Das, S., Mittal, E., Mathema, B., Philips, J. A., & Khader, S. A. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012137 · Cited by 7
Kathamuthu, G. R., Munisankar, S., Banurekha, V. V., Nair, D., Sridhar, R., & Babu, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00706 · Cited by 7
Thomas, S. M., & Olive, A. J. (2023) · Infection and Immunity · doi:10.1128/iai.00060-23 · Cited by 6
Dichotomous roles of RIPK3 in regulating the IFN response and NLRP3 inflammasome in human monocytes
Yang, C., Yuan, R., Brauner, C., Du, Y., Kioon, M. D. A., Barrat, F. J., & Ivashkiv, L. B. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad095 · Cited by 7
Gr1int/high Cells Dominate the Early Phagocyte Response to Mycobacterial Lung Infection in Mice
Ryder, B. M., Sandford, S., Manners, K. M., Dalton, J. P., Wiles, S., & Kirman, J. R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00402 · Cited by 7
Liang, C., Li, X., Li, Q., Zhang, X., Ren, W., Yao, C., Pang, Y., Liu, Y., Li, C., & Tang, S. (2022) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001604 · Cited by 6
Type I Interferon and Interleukin-1 Driven Inflammatory Pathways as Targets for HDT in Tuberculosis
Mayer-Barber, K. D., & Sassetti, C. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-56905-1_14 · Cited by 6
Self-citationBobba, S., Howard, N. C., Das, S., Ahmed, M., Tang, L., Thirunavukkarasu, S., Larsen, M. H., Mathema, B., Divangahi, M., & Khader, S. A. (2023) · mBio · doi:10.1128/mbio.00946-23 · Cited by 6
Nore, K. G., Louet, C., Bugge, M., Gidon, A., Jørgensen, M. J., Jenum, S., Dyrhol‐Riise, A. M., Tonby, K., & Flo, T. H. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad390 · Cited by 6
Kotzé, L. A., van der Spuy, G. D., Leonard, B., Penn‐Nicholson, A., Musvosvi, M., McAnda, S., Malherbe, S. T., Erasmus, M., Scriba, T. J., Koegelenberg, C. F. N., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.839747 · Cited by 6
Wu, C. Y., Ma, J., Xu, Y., Zhang, X., Lao, S., & Yang, B. (2013) · Tuberculosis · doi:10.1016/j.tube.2013.10.008 · Cited by 6
Leisching, G. R., Yennemadi, A. S., Gogan, K. M., & Keane, J. (2024) · European Journal of Immunology · doi:10.1002/eji.202451032 · Cited by 5
Nafiz, T. N., Sankar, P., MISHRA, L., Rousseau, R. P., Saqib, M., Subbian, S., Parihar, S. P., & Mishra, B. B. (2024) · Scientific Reports · doi:10.1038/s41598-024-71180-1 · Cited by 5
Jiang, W., Chen, Y., Yu, C., Zou, B., Lu, Y., Yang, Q., Tang, Z., Mao, W., Li, J., Han, H., et al. (2024) · European Journal of Immunology · doi:10.1002/eji.202350378 · Cited by 5
Vaccination Strategies Against Mycobacterium tuberculosis: BCG and Beyond
Ferluga, J., Yasmin, H., Bhakta, S., & Kishore, U. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-67452-6_10 · Cited by 5
Epidemiological and genetic aspects of pulmonary tuberculosis in Kazakhstan
Yerezhepov, D., Gabdulkayum, A., Akhmetova, A., Abilova, Z., Rakhimova, S., Kairov, U., Akilzhanova, A. R., & Kozhamkulov, U. A. (2024) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2024.102540 · Cited by 5
Deng, T., Cui, J., Lyon, C. J., Zhang, N., Wang, H. Y., Wang, R., & Hsueh, W. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6819-6_2 · Cited by 5
IL-1R1-Dependent Signals Improve Control of Cytosolic Virulent Mycobacteria In Vivo
van der Niet, S., van Zon, M., de Punder, K., Grootemaat, A. E., Rutten, S., Moorlag, S. J. C. F. M., Houben, D., van der Sar, A. M., Bitter, W., Brosch, R., et al. (2021) · mSphere · doi:10.1128/msphere.00153-21 · Cited by 5
Self-citationImmunität gegen Mycobacterium tuberculosis
Nowag, A., & Hartmann, P. (2016) · Der Internist · doi:10.1007/s00108-015-0016-4 · Cited by 5
Peters, J. M., Gideon, H. P., Hughes, T. K., Gunnarsson, C., Maiello, P. A., Mugahid, D., Nyquist, S. K., Bromley, J. D., Blainey, P. C., Junecko, B. A. F., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.24.595747 · Cited by 4
Gao, Y., Zhou, M., Zhang, W., Jiang, J., Ouyang, Z., Zhu, Y., & Li, N. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-4120 · Cited by 4
Salmonella Typhimurium infection inhibits macrophage IFNβ signaling in a TLR4-dependent manner
Shuster, M., Lyu, Z., Augenstreich, J., Mathur, S., Ganesh, A., Ling, J., & Briken, V. (2024) · Infection and Immunity · doi:10.1128/iai.00098-24 · Cited by 4
Hoffmann, G. B., & Perkins, D. J. (2025) · Innate Immunity · doi:10.1177/17534259251367263 · Cited by 4
Mutua, F., Su, R., Mesa, C., Lopez, C., Ball, T. B., & Kiazyk, S. A. K. (2023) · Tuberculosis · doi:10.1016/j.tube.2023.102409 · Cited by 4
Davis, M. J., Martin, R. E., Pinheiro, G. M., Hoke, E. S., Moyer, S., Mayer-Barber, K. D., Chang, Y. C., & Kwon-Chung, K. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.931194 · Cited by 4
Self-citationLiu, Y., Yang, Z., Xiang, Y., Cheng, G., Chen, L., Wang, S., Zang, M., Zhou, N., Zhang, X., Chen, R., et al. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013543 · Cited by 3
B cells and iBALT in TB immunity & pathogenesis
Dutt, T. S., Krause, R. G. E., Hertz, D., Henao-Tamayo, M. I., Leslie, A. J., & Schneider, B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1743572 · Cited by 3
Alveolar macrophages shape tuberculosis susceptibility by delaying protective immunity
Micheli, C., Oliveira, A. R. G., Millan, B., Cardoso, M. S., Araújo, M. R., Duarte‐Oliveira, C., Mendes‐Frias, A., Silvestre, R., Cunha, C., Carvalho, A., et al. (2026) · Mucosal Immunology · doi:10.1016/j.mucimm.2026.02.006 · Cited by 4
Zhao, D., Song, Y.-H., Li, D., Zhang, R., Xu, J., Shi, K., Li, J., Leng, X., Zong, Y., Zeng, F.-L., et al. (2023) · Acta Tropica · doi:10.1016/j.actatropica.2023.106974 · Cited by 3
Chen, Q., Tong, Q., Ge, H., Li, W., Liu, J., Wang, Y., Guo, Z., Quan, F., & Zhang, Y. (2016) · Tuberculosis · doi:10.1016/j.tube.2016.08.007 · Cited by 3
Immunoregulatory macrophages induced by mycobacterial nonpolar lipids
Petrilli, J. D., Estevão, P., Araújo, L. E. D., Müller, I., Yoshinaga, M. Y., Ramos, P. I. P., Chaves‐Filho, A. B., Horta, T., Sorgi, C. A., Miyamoto, S., et al. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkae058 · Cited by 2
Kumar, R., Gandham, S., Bhaskar, V., Praharaj, M. R., Maity, H. K., Sarkar, U., & Dey, B. (2025) · Veterinary Quarterly · doi:10.1080/01652176.2025.2509503 · Cited by 2
Drugs Used in the Treatment of Viral Infections for the Prevention of Airway Remodeling in Asthma
Wieczfińska, J., & Pawliczak, R. (2025) · Mediators of Inflammation · doi:10.1155/mi/5526526 · Cited by 2
Lyadova, I. V. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1717370 · Cited by 2
O’Garra, A. (2025) · Annual Review of Immunology · doi:10.1146/annurev-immunol-010824-041601 · Cited by 2
CHARACTERISTICS OF IMMUNOREACTIVITY IN PATIENTS WITH VARIOUS FORMS OF DIABETIC FOOT ULCER
Mykhaylichenko, V., Kaibov, I., Bondarenko, N., Parshin, D., & Пучкина, Г. (2022) · Archiv Euromedica · doi:10.35630/2199-885x/2022/12/3.17 · Cited by 2
Banks, D. A., Ahlbrand, S. E., Hughitt, V. K., Shah, S., Vogel, S. N., El-Sayed, N. M., & Briken, V. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/425116 · Cited by 2
Evaluation of IL-1 blockade as an adjunct to linezolid therapy for tuberculosis in mice and macaquesPreprint
Winchell, C. G., Mishra, B. B., Phuah, J. Y., Saqib, M., Nelson, S. J., Maiello, P. A., Causgrove, C. M., Ameel, C. L., Stein, B., Borish, H. J., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/792390 · Cited by 1
Inflammasome activation dictates the efficacy of antimycobacterial activity of frontline TB drugsPreprint
Rao, V., Singh, A., Bisht, K., Yadav, N., & Nanda, R. K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.02.646750 · Cited by 2
Type I interferon responses contribute to immune protection against mycobacterial infectionPreprint
Szydlo-Shein, A., de Estrada, B. S.-M. D., Rosenheim, J., Turner, C. T., Chandran, A., Tsaliki, E., Lipman, M. C. I., Kunst, H., Pollara, G., Elks, P. M., et al. (2025) · eLife · doi:10.7554/elife.106799.1 · Cited by 2
Jones, S.-S., Ozturk, M., Kieswetter, N. S., Poswayo, S. K., Hazra, R., Tamgue, O., Parihar, S. P., Suzuki, H., Brombacher, F., & Guler, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.948047 · Cited by 1
Gjerstorff, M. F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1219870 · Cited by 1
Letuka, P., & Zulu, M. Z. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1717609 · Cited by 1
Kim, H., Shin, Y., Choi, H., Kim, K., Kim, H., Kim, H., Lee, W., & Shin, S. J. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111884 · Cited by 1
Fattinger, S. A., Bianca, P., Chavez, R. A., Fairgrieve, M. R., Lee, O. V., Witt, K. C., Rodriguez, J. J., Turcotte, E. A., Brydon, E. C., Dhaliwal, H. S., et al. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.07.014 · Cited by 1
Regulation of Host Response to Mycobacteria by Type I Interferons
Stifter, S. A., Coleman, M. C., & Feng, C. G. (2014) · Springer eBooks · doi:10.1007/978-3-319-09498-4_10 · Cited by 1
Self-citationFlores‐Villalva, S., Reid, C., Rémot, A., Gordon, S. V., & Meade, K. G. (2023) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2023.110575 · Cited by 1
Self-citationAnti-tumor Necrosis Factor-α Antagonists and Tuberculosis
Lim, R., Fisher, D. A., & Field, S. K. (2023) · Integrated science · doi:10.1007/978-3-031-15955-8_32 · Cited by 1
He, J., Zhou, X., Zhang, D. D., Cai, Y., Pan, H., Huang, T., & He, F. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1519216 · Cited by 1
Local Immune Responses in Tuberculosis
Iványi, J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-415847-4.00095-1 · Cited by 1
Interferon-β controls non-tuberculous mycobacterial infection in mice
Norazmi, M. N. (2017) · Virulence · doi:10.1080/21505594.2017.1341035 · Cited by 1
Float Like Bacilli, STING Like a B: Type I Interferons in Tuberculosis
Ernst, J. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2368ed · Cited by 1
Ji, D. X., Chen, K. J., Mukaida, N., Kramnik, I., Darwin, K. H., & Vance, R. E. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/389288 · Cited by 1
Neutrophils reprograms the bone marrow to impair T-cell immunity during tuberculosisPreprint
Saqib, M., McDonough, E., Das, S., Cheng, Z., Sankar, P., Li, F., Yang, Q., Xu, Y., Wang, W., Chen, X., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.28.498035 · Cited by 1
Type I interferon responses contribute to immune protection against mycobacterial infectionPreprint
Szydlo-Shein, A., de Estrada, B. S.-M. D., Rosenheim, J., Turner, C. T., Chandran, A., Tsaliki, E., Lipman, M. C. I., Kunst, H., Pollara, G., Elks, P. M., et al. (2025) · eLife · doi:10.7554/elife.106799 · Cited by 1
Cerón-Rodríguez, J.-M. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Negative regulation of NLRP3 infl ammasome signaling INI-REVIEW M
Chen, S., & Sun, B. (2013)
Thebalancebetweenprotectiveand pathogenicimmuneresponsesinthe TB-infectedlung
Orme, I. M., Robinson, R., & Cooper, A. M. (2015)
Das, M. K., Ray, A. A., Cai, Y., Singhania, A., Graham, C. M., Liao, M., Fountain, J. J., Pearl, J. E., Pareek, M., Haldar, P., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/271627
Avaliação do eixo IL-1/IL-1R na comorbidade obesidade e tuberculose
de Oliveira, R. S. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2019.tde-15102018-113326
Protection from Mycobacterium tuberculosis infection: Learning from exposed but uninfected children
Roy, R. B. (2017) · Spiral (Imperial College London) · doi:10.25560/78539
The role of Lymphoblastic leukemia 1 (Lyl1) in Mycobacterium tuberculosis (Mtb) infection
Jones, S.-S. (2021) · Open University of Cape Town (University of Cape Town)
Yang, C., Bachu, M., Du, Y., Brauner, C., Yuan, R., Kioon, M. D. A., Chesi, G., Barrat, F. J., & Ivashkiv, L. B. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.28.486089
The Immune Interaction between HIV-1 Infection andMycobacterium tuberculosis
Bruyn, E. D., & Wilkinson, R. J. (2017) · ASM Press eBooks · doi:10.1128/9781555819569.ch12
Metabolic biological markers for diagnosing and monitoring the course of tuberculosis
Korotetskaya, M. V., & Rubakova, E. I. (2022) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-mbm-1947
Thomas, S. M., & Olive, A. J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.08.527787
A TNF-IL-1 circuit controls Yersinia within intestinal granulomasPreprint
Matsuda, R., Daniel, S., Zhang, J., Peterson, S. T., Grayczyk, J. P., Herrmann, B. I., Yost, W., O’Neill, R., Bohrer, A. C., Lanza, M. R., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.21.537749
Self-citationLeisching, G. R., Yennemadi, A. S., Gogan, K. M., & Keane, J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.16.571975
The Covid-19 and TB Syndemic: Differences and Similarities
Kaufmann, S. H. E., Sher, A., Sigal, A., & Sawitzki, B. (2023) · Frontiers research topics · doi:10.3389/978-2-8325-4116-6
Self-citationType I interferon responses contribute to immune protection against mycobacterial infectionPreprint
Szydlo-Shein, A., de Estrada, B. S.-M. D., Rosenheim, J., Turner, C. T., Chandran, A., Tsaliki, E., Lipman, M. C. I., Kunst, H., Pollara, G., Elks, P. M., et al. (2024) · medRxiv · doi:10.1101/2024.06.26.24309490
Apolloni, V. B., de Oliveira, R. S., Cipriano, U. G., Corrêa, G. F., Gembre, A. F., Fraga‐Silva, T. F. D. C., Ramalho, L. N. Z., Costa, D. L., & Bonato, V. L. D. (2025) · Immunology · doi:10.1111/imm.13947
Cao, L., & Chang, M. X. (2025) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2025.110442
Pre-clinical Studies and Animal Models
Sathkumara, H. D., Valencia‐Hernandez, A. M., & Kupz, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-94540-3_7
Vankayalapati, A., Somasundram, B., Paidipally, P., Singh, K. P., Vankayalapati, R., & Radhakrishnan, R. K. (2025) · ImmunoHorizons · doi:10.1093/immhor/vlaf046
Protein kinase F regulates the virulence of Mycobacterium tuberculosis
Torres-Juárez, F., Rastogi, S., Young, D. C., Belew, A. T., Baker, P. J., Biswas, V. K., Khan, S. E., El-Sayed, N. M., Moody, D. B., Mayer-Barber, K. D., et al. (2026) · Infection and Immunity · doi:10.1128/iai.00698-25
Self-citationSivakumar, S., Chandramohan, Y., Kathamuthu, G. R., Sekar, G., Kandhasamy, D., Padmanaban, V., Hissar, S. S., Tripathy, S. P., Bethunaickan, R., Baskaran, D., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13294736
Metadata
- Authors
- Mayer-Barber, K. D., Andrade, B. B., Barber, D. L., Hieny, S., Feng, C. G., Caspar, P., Oland, S., Gordon, S., & Sher, A.
- Affiliations
- National Institutes of Health (US)
- University of Oxford (GB)
- Corresponding author
- Mayer-Barber, Katrin D.
- Sher, Alan
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2011-12
- Volume
- 35
- Issue
- 6
- Pages
- 1023-1034
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC3246221
- OpenAlex
- W2023478821
- Cited by
- 418
- References
- 48
- Citations by year
- 2026: 16 · 2025: 26 · 2024: 25 · 2023: 31 · 2022: 33 · 2021: 18 · 2020: 27 · 2019: 31 · 2018: 23 · 2017: 31 · 2016: 38 · 2015: 37 · 2014: 31 · 2013: 37 · 2012: 14
- FWCI
- 17.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (Z99 AI999999)
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases (Y99 AI999999)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- Mycobacterium tuberculosis infection, interleukin-1 alpha, IL-1β, type I interferon, innate immunity, adaptive immunity, monocytes/macrophages, dendritic cells, host resistance, IL-1 signaling, single-cell analysis
- MeSH terms
- Animals, Antigens, Ly, Dendritic Cells, Humans, Interferons, Lung, Mice, Inbred C57BL, Mycobacterium tuberculosis, Phagocytes, Tuberculosis, Pulmonary, Signal Transduction, CD4-Positive T-Lymphocytes, Mice, Knockout, Myeloid Cells, CD11b Antigen, Mice, Interleukin-1alpha, Interleukin-1beta, Interleukin-12 Subunit p40
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review